Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION
Pre-Startup Review (PSUR) for Sanmen Nuclear Power Plant Unit 3 Completed
From July 15 to 30, the Pre-Startup Review (PSUR) for Sanmen Nuclear Power Plant Unit 3 was conducted at the Sanmen nuclear power plant site. The review was organized by the Shanghai Office of the World Association of Nuclear Operators (WANO), and the review team consisted of 21 experts from the WANO Shanghai Office, WANO Tokyo Center, and Korea Hydro & Nuclear Power Co., Ltd. Leaders of Sanmen Nuclear Power Company and personnel from relevant fields participated in this activity. The review aimed to systematically and comprehensively evaluate the readiness of Unit 3 prior to startup, identify areas for improvement, analyze causes, and propose improvement recommendations. Through site inspections, work observations, document package reviews, and personnel interviews, the WANO review team conducted a thorough assessment of...
2026-08-03
Japanese research team experimentally demonstrates that fusion plasma fluctuations can drive inward particle transport
2026-08-03
Wang Min, Deputy Director of the China International Nuclear Fusion Energy Program Execution Center, Led a Delegation to Thailand and Malaysia to Attend China-Thailand and China-Malaysia Bilateral Science and Technology Cooperation Consultations on Nuclear Fusion
2026-08-03
U.S. Nuclear Regulatory Commission (NRC) Proposed Rule to Update Radioactive Material Transport Regulations for New Reactor Technologies
2026-08-03
Global nuclear power generation hits record high in 2025, with net growth mainly driven by China
2026-08-03
Uzbekistan Updates Licensing Rules for Nuclear Energy and Ionizing Radiation Sources
2026-08-03
Annual maintenance outage begins at Finland's Loviisa nuclear power plant, spanning August 2 to October 18
2026-08-03
Serbia Launches Nuclear Program: Experts to Train in France for 17 Months, First Nuclear Power Plant Expected by 2040
2026-08-03
Behind India's Nuclear Power Expansion: Where Does Radioactive Waste Go? Government Details Management Process in Parliament for First Time
2026-08-03
To thoroughly implement the Ecological Environment Code and further enhance radiation safety management in the field of nuclear technology utilization, the 2026 Special Training Course on the Application of the Ecological Environment Code and Radiation Safety Practices for Nuclear Technology Utilization, hosted by the Nuclear and Radiation Safety Center of the Ministry of Ecology and Environment (hereinafter referred to as the Center), was successfully held in Xi'an, Shaanxi Province, from July 27 to 30. Nearly one hundred trainees from 67 institutions nationwide, including ecological environment departments, research institutes, medical facilities, and environmental impact assessment (EIA) compilation agencies, gathered together to study the new regulations and discuss practical matters, empowering the industry's high-quality development. This training closely followed the pulse of industry development, focusing on the new situations and challenges...
2026-08-03
The General Department of Customs and Excise of Cambodia recently organized a delegation for a working visit to Jiangsu Province, China, focusing on smart customs development and advanced scanning inspection technologies, with the aim of advancing Cambodia's customs modernization reform and digital transformation, enhancing trade facilitation and customs supervision capacity. According to the General Department of Customs and Excise of Cambodia, from July 27 to 31, Kun Nhem, Special Representative of the Cambodian Prime Minister and Director General of Customs and Excise, led a delegation to visit Jiangsu Province and conducted an inspection and exchange at Nuctech Company Limited. The visit was intended to understand the application of smart customs systems and customs inspection technologies in actual operations, in support of Cambodia's Customs Reform...
2026-08-03
Ratio Therapeutics, Inc., a U.S. clinical-stage pharmaceutical company, recently announced the completion of a $70 million Series C financing round. The company stated that following this round, its cumulative total financing has exceeded $240 million. According to the announcement, this round saw participation from existing investors Duquesne Family Office and Bristol Myers Squibb, while also bringing in new investors such as Catalio Capital Management, Eli Lilly and Company, and Wasatch Group. Ratio Therapeutics stated that the proceeds will be used to advance the clinical development of its targeted radiotherapeutic product pipeline and expand manufacturing infrastructure. The company plans to continue advancing the ATLAS study, which is evaluating its lead radiotherapeutic agent [Ac-2...
2026-08-03
Recently, the national standard "Methods of Analysis of Uranium Ore Concentrate - Part 1: Determination of Uranium - Ferrous Sulfate Reduction - Potassium Dichromate Titration Method" (GB/T 11848.1-2026), compiled by CNNC Mining and Metallurgy Technology Group Co., Ltd. (Beijing Research Institute of Chemical Engineering and Metallurgy, CNNC), was officially released. With this, all 15 national standard methods for "Methods of Analysis of Uranium Ore Concentrate" (GB/T 11848.2-11848.16, implemented in May 2026) led by our company have been fully released. Uranium ore concentrate is an important intermediate product in the nuclear fuel cycle, with its core value lying in the uranium it contains. The determination of uranium content is a crucial link throughout the entire industrial chain from ore to nuclear fuel. This is not merely a simple compositional analysis, but a core step in ensuring economic benefits, product compliance, process safety, and conformity with international regulations. The control of impurity elements plays an important role in the uranium purification and conversion process. The determination of impurity elements is primarily aimed at meeting product control and quality assurance requirements, ensuring downstream process safety, and supporting nuclear safeguards and forensic traceability. The new series of analytical methods is better adapted to modern production processes and detection techniques.
2026-08-03
Montpellier, France, is testing a mosquito control strategy that does not rely on chemical insecticides by releasing X-ray-sterilized sterile male tiger mosquitoes, in response to the spread of tiger mosquitoes and the associated disease transmission risks. The trial has been underway since 2025 in the Malbosc residential area of Montpellier. This area is suitable for tiger mosquito breeding, and the trial team releases sterile male tiger mosquitoes at approximately 30 release points twice a week, about 100,000 per release, equivalent to roughly 200,000 per week across an area of about 50 hectares. The method is based on the sterile insect technique. Since only female mosquitoes bite and suck blood and may transmit viruses, and females typically mate only once in their lifetime, researchers release male mosquitoes that have lost their reproductive capacity after X-ray treatment into the wild to mate with wild females. The eggs subsequently laid by females fail to fertilize normally, thereby reducing the next generation of mosquito populations.
2026-08-03
August 3 news, United Imaging Healthcare Japan Co., Ltd. announced that the first unit in Japan of its new-generation digital PET/CT scanner uMI Panvivo has been put into clinical use at Saitama Central Clinic, located in Omiya-ku, Saitama City. Saitama Central Clinic is a medical institution specializing in diagnostic imaging. Since its opening in 2009, the clinic has continuously conducted comprehensive cancer screening centered on PET/CT scans, and provides FDG-PET cancer examination services based on the needs of local medical institutions, with an annual PET/CT examination volume ranking among the highest in Japan. With the introduction of uMI Panvivo, the clinic expects to further shorten examination time and enhance image quality on the basis of its existing high-precision diagnostic imaging...
2026-08-03
On August 3, Deepnoid announced the signing of a supply contract for M4CXR with Pusan National University Hospital. M4CXR is a generative AI-based preliminary report generation solution for chest X-rays that generates preliminary reports during chest X-ray examinations to assist medical staff in image interpretation. This is the first supply agreement signed after M4CXR received approval from the Ministry of Food and Drug Safety of South Korea for market release as a digital medical device. According to the introduction, the system is expected to improve the efficiency of chest X-ray reading and provide clinical support for the early detection of lung diseases and suspected cancerous lesions. This collaboration is also part of the AI clinical system support project for regional responsible medical institutions under the Ministry of Health and Welfare of South Korea...
2026-08-03
